| Literature DB >> 35432189 |
Yan-Rong Li1,2, Wei-Yu Chou1, Wai-Kin Chan1, Kai-Lun Cheng3,4, Jui-Hung Sun1, Feng-Hsuan Liu1,2, Szu-Tah Chen1,2, Miaw-Jene Liou1,2.
Abstract
Background: Radiofrequency ablation (RFA) for benign thyroid nodules is one kind of scarless treatment for symptomatic or cosmetic benign thyroid nodules. However, how to train RFA-naive physicians to become qualified operators for thyroid RFA is an important issue. Our study aimed to introduce a successful training model of thyroid RFA. Materials andEntities:
Keywords: medical education; nodule; radiofrequency ablation; thyroid; training model
Mesh:
Year: 2022 PMID: 35432189 PMCID: PMC9009177 DOI: 10.3389/fendo.2022.809835
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Chicken hearts simulated into thyroid nodules (arrowhead), three-layer pork meats simulated into peri-thyroid skin structure, and gel bottles simulated into trachea (arrow).
Figure 2Sequential echo-guided procedures for training the trans-isthmic approach method and the moving shot technique.
Figure 3The successful ablations were defined as the color of chicken hearts from bright red to off-white, indicating that the meat was fully cooked.
Baseline characteristics in 23 patients with thyroid radiofrequency ablation.
| Clinical characteristics | Value |
|---|---|
| Main nodule for RFA | 23 |
| Age at treatment (year) | 51 (43-55) |
| Female gender | 17 (73.91) |
| Largest diameter (cm) | 3.50 (2.80-4.01) |
| Initial volume | 7.23 (4.49-13.09) |
| Small (< 10 ml) | 9 (39.13) |
| Medium (> 10 to ≤ 20 ml) | 5 (21.74) |
| Large (> 20 to ≤ 30 ml) | 6 (26.09) |
| Very large (> 30 ml) | 3 (13.04) |
| Solidity > 50% | 23 (100) |
| Solidity > 90% | 22 (95.65) |
| Euthyroid status | 23 (100) |
Data were presented as median (interquartile range) or number (percentage).
Outcomes of main nodules after thyroid radiofrequency ablation.
| Initial | 1 month after RFA | 3 month after RFA | 6 month after RFA | 12 month after RFA | |
|---|---|---|---|---|---|
| (N = 23) | (N = 23) | (N = 23) | (N = 23) | (N = 18) | |
| Volume of nodule (mL) | 7.23 (4.49-13.09) | 3.49 (2.36-6.13)* | 1.93 (1.29-4.45)* | 1.42 (0.63-2.30)* | 1.30 (0.22-2.42)* |
| VRR (%) | 0 | 40.89 (32.26-56.78)* | 69.62 (60.17-79.06)* | 79.89 (61.91-85.44)* | 82.00 (62.17-87.63)* |
| Major complications | |||||
| Voice change | 2 | 0 | 0 | 0 | 0 |
| Horner syndrome | 0 | 0 | 0 | 0 | 0 |
| Brachial plexus injury | 0 | 0 | 0 | 0 | 0 |
| Nodule rupture | 0 | 0 | 0 | 0 | 0 |
| Minor complications | |||||
| Wound pain | 3 | 0 | 0 | 0 | 0 |
| Skin burn | 0 | 0 | 0 | 0 | 0 |
| Hematoma | 0 | 0 | 0 | 0 | 0 |
| Euthyroid status (%) | 100 | 100 | 100 | 100 | 100 |
RFA, radiofrequency ablation; VRR, volume reduction rate; N, number.
Data were presented as median (interquartile range), number, or percentage.
*p value < 0.05 when compared with the initial nodules.
Figure 4The median changes in the volume of nodules and volume reduction rate during the follow-up.
Figure 5One of our real patients with good response after thyroid radiofrequency ablation (RFA). (A) before thyroid RFA (B) near 97% volume reduction rate 12 months after thyroid RFA.